Delivery Order SPE2DB25D3006-SPE2DB25FXJVC
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,903.13, is for the delivery of Zolmitriptan 2.5 mg tablets to support military healthcare programs. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...
- This federal contract award is a delivery order valued at $3,089.46 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of zolmitriptan 5 mg orally disintegrating tablets to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Zolmitriptan 2.5 mg tablets. The contract has a ceiling value of $1,383.12 and an ultimate completion date of March 1, 2022. The contract is a firm-fixed-price arrangement, and it was not set aside for any specific business type. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,621.40 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,407,890 zolmitriptan 5 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999. The award is for the supply of zolmitriptan 5 mg tablets to support federal healthcare programs. The total ceiling value of this specific delivery order is $1,076.94, with a firm fixed-price pricing type. The contract does not have a set-aside designation and is...
- This award is a delivery order under a larger indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which provides a wide range of prescription medications, over-the-counter drugs, and medical supplies to support various government agencies and healthcare programs. The specific delivery order is for...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,852.07 firm fixed-price delivery order is for the supply of 4566640118 - Zolmitriptan 5 mg Tablet Unit Dose 3's, a generic medication. The award is not associated with a set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,424.52 delivery order contract is for the supply of Zolmitriptan 2.5 mg tablets, a medication used to treat migraine headaches. The contract has a firm fixed price and a completion date of December 18, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of pharmaceutical products. Specifically, the contract is for the supply of Zolmitriptan 5 mg orally disintegrating tablets. The contract has a ceiling value of $1,072.07 and is a firm fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Zolmitriptan 2.5 mg ODT UD 6S, a migraine medication, with a ceiling value of $1,281.12 and a period of performance through July 3, 2025. The contract is not set-aside and was awarded on a firm-fixed price basis. AmerisourceBergen Drug Corp holds a larger Indefinite...
- SPE2DB25D3006Indefinite Delivery Contract
- SPE2DB25D3006-SPE2DB25FXJVCDelivery Order
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of Zolmitriptan 5 mg Tablet Unit Dose 3s, a prescription medication, with a ceiling value of $9,903.39 and a period of performance extending through July 16, 2025. The contract is not set-aside and was awarded on a firm-fixed price basis. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for various government agencies, including the Defense Health Agency and U.S. Coast Guard. This delivery order falls under the scope of that larger IDC contract, enabling AmerisourceBergen to fulfill a range of federal medical supply requirements, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 7/15/25 |